SEC Form 4 · accession 0001127602-16-062563
Alkermes plc. · ALKS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
nancy lynn snyderman M.D.
Director
Period of report
Sep 14, 2016
Accepted (ET)
Sep 15, 2016 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001520262
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non Qualified Stock Option (Right to Buy)F1 | $47.65 | Sep 14, 2016 | A | 27,400 | A | Sep 14, 2017 | Sep 14, 2026 | Ordinary Shares | 27,400 | 27,400 | D |
| Non Qualified Stock Option (Right to Buy)F2 | $47.65 | Sep 14, 2016 | A | 16,200 | A | Sep 14, 2017 | Sep 14, 2026 | Ordinary Shares | 16,200 | 16,200 | D |
Explanation of responses
- F1This option vests in 3 equal annual installments commencing on 9/14/17.
- F2This option becomes exercisable in full on 9/14/17.